Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Pharmazie ; 71(8): 455-459, 2016 08 01.
Article in English | MEDLINE | ID: mdl-29442032

ABSTRACT

Ampelopsin is a well-known flavonoid which has variety of biological and pharmacological actions including anticancer effects and induction of apoptosis on the several cancer cell lines. The present study aimed to evaluate the role of ampelopsin sodium (Amp-Na) in the mitochondrial-mediated apoptosis of human lung adenocarcionma SPC-A-1 cells. The analysis of cell proliferation and ultrastructure were performed. Furthermore, to clarify its action mechanism by determining the mitochondrial membrane potential (Δψm), intracellular calcium (Ca2+) concentration, mitochondrial nitric oxide (NO) level and total ATPase activity. The results showed that Amp-Na markedly inhibited the SPC-A-1 cell proliferation and caused ultrastructural apoptosis feature in SPC-A-1 cells in a dose-dependent manner. Amp-Na led to a rapid and sustained Ca2+ elevation and Δψm reduction, and induced the mitochondrial NO production and decreased the total ATPase activity in SPC-A-1 cells. The results enhance the potential of Amp-Na as a therapeutic drug for treating lung cancer, and provide new information for mechanism of Amp-Na which induces mitochondrial-mediated apoptosis in tumor cells.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Flavonoids/pharmacology , Lung Neoplasms/drug therapy , Mitochondria/drug effects , Adenocarcinoma/pathology , Adenocarcinoma/ultrastructure , Adenocarcinoma of Lung , Adenosine Triphosphatases/metabolism , Calcium/metabolism , Cell Line, Tumor , Cell Proliferation , Dose-Response Relationship, Drug , Humans , Lung Neoplasms/pathology , Lung Neoplasms/ultrastructure , Membrane Potential, Mitochondrial/drug effects
2.
Mol Med Rep ; 5(2): 469-72, 2012 02.
Article in English | MEDLINE | ID: mdl-22075845

ABSTRACT

The objective of the present study was to investigate the expression of paxillin and focal adhesion kinase (FAK) mRNA in esophageal carcinoma tissues, and their relationship with clinicopathological parameters, as well as to analyze the correlation of paxillin and FAK mRNA levels in esophageal carcinoma. By using reverse transcription polymerase chain reaction (RT-PCR), the mRNA expression levels of paxillin and FAK were detected in 121 samples of esophageal carcinoma, 43 samples of atypical hyperplasia and 56 samples of normal esophageal mucosa. The results showed that the positive rates of paxillin and FAK mRNA expression in esophageal carcinoma were 87.6 and 80.17%, respectively, which were significantly higher (P<0.05) than those in atypical hyperplasia (44.19 and 39.53%) and normal esophageal mucosa (5.36 and 12.5%). Notably, paxillin and FAK mRNA expression levels were significantly correlated with the differentiation degree and depth of invasion of esophageal carcinoma and with lymph node metastasis (P<0.05). In addition, paxillin and FAK mRNA expression levels in esophageal carcinoma were positively correlated (r=0.4804, P=0.000). In conclusion, the combined detection of paxillin and FAK mRNA expression is expected to provide a theoretical basis for the molecular diagnosis of esophageal carcinoma.


Subject(s)
Carcinoma/metabolism , Esophageal Neoplasms/pathology , Focal Adhesion Kinase 1/metabolism , Gene Expression Regulation , Paxillin/metabolism , RNA, Messenger/metabolism , Adult , Aged , Aged, 80 and over , Carcinoma/pathology , Esophageal Neoplasms/metabolism , Female , Focal Adhesion Kinase 1/genetics , Humans , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Invasiveness , Paxillin/genetics
SELECTION OF CITATIONS
SEARCH DETAIL